Nouvelle déclaration d'incident
No de la demande: 2020-1507
Numéro de référence du titulaire d'homologation: USA-BAYERBAH-2019-US0045563
Nom du titulaire (nom légal complet, aucune abbréviation): Bayer Inc
Adresse: 2920 matheson BLVD
Ville: Mississaugua
État: ON
Pays: Canada
Code postal /Zip: L4W 5R6
Incident chez un animal domestique
Pays: UNITED STATES
État: UNKNOWN
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. 11556-155
Nom du produit: Seresto Collar Large dog
Autre (préciser)
collarOui
Autres unités: collar
Site: Animal / Usage sur un animal domestique
Autre
Dog / Chien
Boxer
1
Femme
10
36.8
kg
Cutanée
Unknown / Inconnu
Unknown / Inconnu
Système
Unknown / Inconnu
Non
Non
Mort
Treatment / Traitement
(p.ex. description des symptômes tels que la fréquence et la gravité
On approximately 01-Apr-2019 was administered 1 tube of Advantage Multi for Dogs (10% imidacloprid + 2.5% moxidectin) Topical Solution (Imidacloprid and Moxidectin) 4.0mL topically by the owner. On approximately 15-Apr-2019, the dog exhibited a nonspecific behavioral change, agitation, dyspnea and coughing. On approximately 01-May-2019, the dog was evaluated by a veterinarian then referred to a cardiologist. Unspecifieddiagnostics revealed congestive heart failure. The dog was administered a regimen of unspecified cardiac medications orally. The dog again was administered 1 tube of Advantage Multi for Dogs (10% imidacloprid + 2.5% moxidectin) Topical Solution (Imidacloprid and Moxidectin) 4.0 mL topically by the owner. On approximately 10-May-2019, the behavioral change, agitation, dyspnea and coughing resolved.On approximately 01-Jun-2019 the dog was administered 1 tube of Advantage Multi for Dogs (10% imidacloprid + 2.5% moxidectin) Topical Solution (Imidacloprid and Moxidectin) 4.0mL topically by the owner. On approximately 09-Jul-2019, the dog exhibited pruritus and fleas were visualized. On approximately 21-Jul-2019, the dog was administered 1 tube of Advantage Multi for Dogs (10% imidacloprid + 2.5% moxidectin) Topical Solution (Imidacloprid and Moxidectin) 4.0mL topically by the owner. On approximately 03-Aug-2019, the dog exhibited aural discharge and aural pruritus.On 05-Aug-2019, the dog was evaluated by a veterinarian and diagnosed with otitis. The clinical signs continued. Follow up received on 09-Sep-2019: On an unknown date in Aug2019, the canine had one Seresto (imidacloprid and Flumethrin) Large dog collar placed around the neck by the owner. On 30Aug2019, the canine died. No necropsy was performed. No more information is expected this case is closed.
Mort